Back to AbbVie.com
|Investors
极光vqn官网-极光加速器正版官网-极光爬墙专用加速器-极光vqn官网
极光vqn官网-极光加速器正版官网-极光爬墙专用加速器-极光vqn官网
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world's greatest health challenges.
极光vqn官网-极光加速器正版官网-极光爬墙专用加速器-极光vqn官网
AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives. Today, our passionate AbbVie team has approximately 47,000 employees working together to help patients around the world.
Shareholder contacts | 哔咔漫画用免费加速器 | Email alerts
极光vqn官网-极光加速器正版官网-极光爬墙专用加速器-极光vqn官网
极光vqn官网-极光加速器正版官网-极光爬墙专用加速器-极光vqn官网
Answers to questions concerning AbbVie stock purchase, dividends, and how to contact AbbVie's transfer agent and Investor Relations.
(Common Stock) Common Stock
Price
Change
极光vqn官网-极光加速器正版官网-极光爬墙专用加速器-极光vqn官网
Upcoming events and
latest webcast
View all upcoming and past events.
The principal market of AbbVie's common shares is the New York Stock Exchange. Shares are also listed on the Chicago Stock Exchange and traded on various regional and electronic exchanges.